FDA clears Mobile MIM for x-ray, radiation oncology

Mobile MIM has received FDA 510(k) clearance for Mobile MIM 3.0 for diagnostic x-ray and ultrasound viewing, as well as radiation treatment plan review and approval.

Radiation oncologists can use Mobile MIM to review dose volume histograms, isodose curves, contours and images for treatment plans, according to Cleveland-based MIM Software.

Mobile MIM is a thick client that brings the data to the device for manipulation, independent of network performance. Device-level hardware encryption provides security for HIPAA compliance, and users can remove data from the device after viewing. Images are displayed as they download and data can be downloaded to Mobile MIM using MIMcloud or an on-site MIM workstation.

MIM Software also plans to launch a co-branded version of the app with partner Accuray. The co-branded version, PlanTouch, will have an interface that allows physicians to review and approve a CyberKnife treatment plan via a direct link.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup